Niger

in page functions
[French]
Total population (2016) 20,715,282
Birth cohort (2016) 1,018,244
Surviving Infants (surviving to 1 year per year, 2016) 963,947
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 96/1000
World Bank Index, IDA (2012) 3.39
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 44

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Niger

Type of support

Approvals

2001-2020 (US$)
(28 Sep 2016)

Commitments

2001-2020 (US$)
(28 Sep 2016)

Disbursements

2000-2016 (US$)
(28 Sep 2016)

% Disbursed

(28 Sep 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Cash Support (CASHSUPP) $235,000 $260,000 $235,000 100%
Health system strengthening (HSS 1) $3,986,000 $3,986,000 $3,602,446 90%
Health system strengthening (HSS 2) $24,792,106 $40,025,092 $17,164,564 69%
HPV Demo (NVS) $599,142 $599,142 $610,200 102%
Immunisation services support (ISS) $8,055,365 $8,055,365 $7,398,724 92%
Injection safety support (INS) $943,757 $943,757 $943,757 100%
IPV (NVS) $1,664,720 $2,724,220 $1,402,617 84%
Meningitis A - mini catch-up campaign (NVS) $4,905,500 $4,905,500
Meningitis A - mini catch-up op.costs (OPC) $3,802,456 $3,802,456
Penta (NVS) $43,493,651 $43,493,651 $42,601,223 98%
Pneumo (NVS) $36,924,911 $36,924,911 $43,740,928 118%
Rotavirus (NVS) $11,326,336 $11,326,336 $11,495,117 101%
Vaccine Introduction Grant (VIG) $2,825,500 $2,825,500 $2,825,500 100%
Yellow Fever (NVS) $4,414,792 $4,414,792 $4,886,058 111%
Total $147,969,236 $164,286,722 $136,906,133

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Niger DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 90%
M:F sex ratio at birth (2016) 1.05
Household survey: DTP3 coverage for male (2011) 67.50%
Household survey: DTP3 coverage for female (2011) 68.60%
Household survey: Last DTP3 survey (2011) 68%
% districts achieving > 80% DTP3 coverage (2015) 75%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 73%

Breakdown of support

Non-vaccine support Vaccine support
23% 77%
$31,916,989 $104,736,139

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Niger

19 September 2016

Stockpiling

On the frontline: Gavi’s support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

27 July 2016

First Sudanese child to receive Meningitis A vaccine as part of routine immunization.

Sudan: first to introduce life-saving meningitis A vaccine into routine immunization

Children in Sudan are set to become the first in the Meningitis belt to benefit from the introduction of Meningitis A vaccine into a routine immunization programme.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

close icon

modal window here